iHuman Inc.
corporate_fare Company Profile
iHuman Inc. (NYSE:IH) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 7 items for IH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-29, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for IH spans 6-K.
Recent high-impact activity:
- iHuman Swings to Q2 Loss as Revenue Falls 18% on China's Declining Newborn Population
- iHuman Q2 Revenue Drops 18% as China's Newborn Decline Hits Demand
- iHuman Reports Sharp Q1 Revenue & Profit Decline, Swings to Operating Loss
- iHuman Q1 Revenue Plunges Amid China's Declining Newborn Population
- iHuman Acquires AI Learning Platforms for ~$13M-$19M, Appoints New Co-CEO & CSO
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 1,101 shares in IH as of the September 15, 2026 settlement, a 78.7% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 15.7% of IH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
IH files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.